Dr. Helen E. Rhodes, MD

Dr. Rhodes practices at Socorro General Hospital in Socorro, New Mexico, part of Presbyterian Healthcare Services.

Dr. Rhodes' NPI, 1043311194, was assigned on September 25, 2006. Dr. Rhodes graduated from Texas Tech University Health Sciences Center School of Medicine in 1988. Dr. Rhodes' Oregon license number on file is MD214126.

Dr. Rhodes' primary practice is Socorro General Hospital, at 1202 Highway 60 West, Socorro, NM 87801 in Socorro County. The practice phone is (575) 835-1140.

Dr. Rhodes' primary practice is Socorro General Hospital in Socorro, New Mexico, part of Presbyterian Healthcare Services. Dr. Rhodes is also affiliated with HCA Houston Healthcare Clear Lake. The medical group on file is Presbyterian Medical Group. Dmand AI also links Dr. Rhodes to 2 more group practices and clinics, 1 home health agency, 1 hospice and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Rhodes practices, 6 sites in all. Vendor and product names are available with a free account.

Obstetrics and gynecology is Dr. Rhodes' primary specialty in the NPI Registry, under taxonomy code 207V00000X. Dr. Rhodes is board certified in obstetrics & gynecology by the American Board of Obstetrics and Gynecology. Dmand AI has Dr. Rhodes' licenses on file in 7 states: Oregon, New Mexico, Hawaii, Texas, Arizona, Colorado and Idaho.

Dmand AI lists menopause and vaginal infection among the conditions Dr. Rhodes treats.

CMS data shows 68 Medicare services from Dr. Rhodes across 2 procedure codes in 2024, for 64 Medicare patients. Medicare paid $4,671 for them. Every service was in an office.

CMS counts 64 Medicare patients who saw Dr. Rhodes in 2024. The largest group is 65 to 74, with 40 patients. 73% of them have high cholesterol, and 67% have high blood pressure. Their average risk score is 0.75, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Rhodes' median patient age at 46, with 97% women.

In 2024, Dr. Rhodes wrote 137 Medicare Part D claims for 47 patients. 82% of them were for generic drugs. CMS names the drug for 57 of them, across 2 drugs with 11 or more claims each, at $3,555 in total drug cost. In 2023, CMS named 79 claims across 5 drugs.

Dr. Rhodes accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 11 papers to Dr. Rhodes, published from 2005 to 2013. 2013 was the busiest year, with 3. The most frequent topics are Carcinoma in Situ, Uterine Cervical Dysplasia and Algorithms. Dr. Rhodes has published most often in Gynecol Oncol. Dr. Rhodes' most frequent co-authors are Andrea M. Milbourne, MD, Jubilee Brown, MD and Michele Follen, MD, PhD.

Dmand AI links Dr. Rhodes to 2 clinical trials. Conditions studied include Uterine Cervical Dysplasia and Precancerous Conditions. M.D. Anderson Cancer Center sponsors the most, 2.

CMS Open Payments shows 202 general payments to Dr. Rhodes from 26 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 93% of the total. CSL Behring paid the most, $97,103.

Dmand AI lists 1 award for Dr. Rhodes.

Dr. Rhodes graduated from Texas Tech University Health Sciences Center School of Medicine in 1988. Dr. Rhodes is a member of American College of Obstetricians and Gynecologists, AMA and The Menopause Society.

Dr. Rhodes is in network with 22 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. PPO plans come from the most carriers, 14. Check the plan with the practice before a visit.